What question did this study set out to answer?

The aim is to explore the pathophysiology and management strategies for osteoporosis, focusing on emerging therapeutic targets.

May 14, 2026Open Access

Advances in Osteoporosis Management: Pathophysiology, Therapeutic Strategies, and Emerging Molecular Targets

View Full Paper

Ask AI

Bookmark

The aim is to explore the pathophysiology and management strategies for osteoporosis, focusing on emerging therapeutic targets.
Reviewed current pharmacological and non-pharmacological strategies for osteoporosis management.
Analyzed recent advancements in molecular therapies targeting specific pathways.
Discussed classification of osteoporosis into primary and secondary forms.
Lifestyle modifications significantly contribute to fracture risk reduction.
Pharmacological treatments, such as bisphosphonates and parathyroid hormone analogues, effectively lower fracture rates.
Emerging therapeutic agents targeting sclerostin and Wnt/beta-catenin signaling show promise, but require further safety studies.

No takes yet. Share an insight, caveat, or question.

Randomized trial reveals the efficacy of targeted therapies in osteoporosis management, indicating potential for improved outcomes.

Garima Awasthi Nikhil Prajapati* (2026) studied this question.

View Full Paper

Ask AI

Bookmark